Your browser doesn't support javascript.
loading
Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.
Sándor, P S; Di Clemente, L; Coppola, G; Saenger, U; Fumal, A; Magis, D; Seidel, L; Agosti, R M; Schoenen, J.
Afiliação
  • Sándor PS; Headache and Pain Unit, Neurology Department, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.
Neurology ; 64(4): 713-5, 2005 Feb 22.
Article em En | MEDLINE | ID: mdl-15728298
ABSTRACT
Riboflavin, which improves energy metabolism similarly to coenzyme Q10 (CoQ10), is effective in migraine prophylaxis. We compared CoQ10 (3 x 100 mg/day) and placebo in 42 migraine patients in a double-blind, randomized, placebo-controlled trial. CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat 3). CoQ10 is efficacious and well tolerated.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquinona / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Neurology Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Suíça
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquinona / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Neurology Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Suíça